Rozanne de Veer

Rozanne de Veer is a dedicated researcher at Erasmus Medical Center, specializing in Gastroenterology & Hepatology. Her primary focus is on Primary Biliary Cholangitis (PBC), a chronic autoimmune liver disease. She is actively involved in multiple international research collaborations including the Global & ERN Rare-Liver PBC Study Groups and the Dutch PBC Study Group, contributing significantly to advancing knowledge in liver disease research and transplantation outcomes.

Dr. de Veer's research interests center on understanding patient outcomes in Primary Biliary Cholangitis, with particular emphasis on disease progression, treatment efficacy, and long-term management strategies. Her work spans epidemiological studies examining the incidence and prevalence of PBC in the Netherlands, as well as clinical investigations into liver transplantation outcomes for PBC patients. She has made significant contributions to understanding the role of liver stiffness measurement in monitoring disease progression and evaluating prognostic scores for predicting outcomes after liver transplantation.

Her recent publications reveal a strong focus on translational research that bridges clinical practice with scientific investigation. The articles show a consistent pattern of large-scale collaborative studies involving multiple international centers, indicating her prominent role in the global PBC research community. Her work particularly emphasizes real-world clinical applications, with studies examining calcineurin inhibitors in transplantation, epidemiological patterns of rare liver diseases, and non-invasive monitoring techniques for disease progression.

Dr. de Veer has been actively involved in several major research consortia including the European Liver and Intestine Transplant Association (ELTR) and the Global PBC Study Group. Her collaborative approach is evident in her extensive co-authorship networks spanning multiple countries and institutions, reflecting the international nature of modern hepatology research. She has contributed to significant advancements in understanding PBC epidemiology in the Netherlands through nationwide cohort studies, providing valuable data for healthcare planning and resource allocation for this rare condition.